Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer
Language English Country Great Britain, England Media print-electronic
Document type Editorial
PubMed
31385744
DOI
10.2217/imt-2019-0083
Knihovny.cz E-resources
- Keywords
- BCG unresponsive, bacillus Calmette-Guérin, bladder cancer, immunotherapy, non muscle invasive bladder cancer, salvage therapies,
- MeSH
- Adjuvants, Immunologic MeSH
- BCG Vaccine immunology MeSH
- Cytotoxicity, Immunologic MeSH
- Immunotherapy methods MeSH
- Humans MeSH
- Tumor Microenvironment MeSH
- Urinary Bladder Neoplasms immunology therapy MeSH
- Salvage Therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Editorial MeSH
- Names of Substances
- Adjuvants, Immunologic MeSH
- BCG Vaccine MeSH
Department of Urology 2nd Faculty of Medicine Charles University 15006 Prague Czech Republic
Department of Urology Comprehensive Cancer Center Medical University of Vienna 1090 Vienna Austria
Department of Urology University of Texas Southwestern Dallas TX 75390 USA
Department of Urology Weill Cornell Medical College New York NY 10065 USA
Research Center for Evidence Based Medicine Tabriz University of Medical Sciences 5166 Tabriz Iran
References provided by Crossref.org
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer